NCT06740253View on ClinicalTrials.gov

Safety and Acceptability Study of a Placebo Antibody-Based Nonhormonal Contraceptive Intravaginal Ring

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

July 28, 2025

Study Completion Date

July 28, 2025

Conditions
Healthy Female Subjects
Interventions
DEVICE

Placebo intravaginal ring (IVR)

Antibody-Based Nonhormonal Placebo Contraceptive Intravaginal Ring

Trial Locations (1)

77555

University of Texas Medical Branch, Galveston

Sponsors

Collaborators (1)

Mucommune, LLC.
All Listed Sponsors
collaborator

Mucommune, LLC.

UNKNOWN

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

The University of Texas Medical Branch, Galveston

OTHER

NCT06740253 - Safety and Acceptability Study of a Placebo Antibody-Based Nonhormonal Contraceptive Intravaginal Ring | Biotech Hunter | Biotech Hunter